You are here

CCS says no to S$137m Parkway, Fortis deal

Transaction involving acquisition of RadLink-Asia called off following CCS provisional decision to block proposal

Singapore

THE Competition Commission of Singapore (CCS) said on Monday that it had blocked last week the S$137 million proposed acquisition of RadLink-Asia and its subsidiaries by Parkway Holdings.

Both Fortis Healthcare Singapore, which owns RadLink-Asia, and Parkway, have since